The Japan antibiotics market, valued at USD 1.41 billion in 2024, is anticipated to grow at a CAGR of 4.0% from 2025 to 2034, with segment-wise performance revealing distinct trajectories across drug classes, formulations, and clinical applications. The market is segmented primarily by therapeutic class—beta-lactams, fluoroquinolones, glycopeptides, macrolides, and newer agents such as...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek